Physician profile
Dennis A Ausiello
NPI 1316938962
$4,579,138.15
in general payments reported to CMS, 2019-2025
3 companies · $381K in 2025
The $381K reported for 2025 was more than what 99% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685K · 2020: $745K · 2021: $698K · 2022: $687K · 2023: $684K · 2024: $699K · 2025: $381K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.7M · Travel and Lodging: $21K · Food and Beverage: $3,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,739,819.82 |
| Travel and Lodging | $20,932.29 |
| Food and Beverage | $3,762.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $3,128,732.00 | 2019-2025 | |
| Pfizer INC. | $1,412,906.15 | 2019-2025 | |
| Seres Therapeutics, INC. | $37,500.00 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Ausiello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.